SARS-CoV-2 neutralizing antibody titers are well-correlated with anti-spike antibodies

Live viral neutralizing antibody titers are widely accepted as a good measure of immunity, yet conducting the assays are time-consuming and laborious making them suboptimal for population level measurements.